CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 95 filers reported holding CYTOSORBENTS CORP in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 22 | -99.8% | 0.00% | – |
| Q4 2020 | $94,000 | +77.4% | 11,792 | +11.0% | 0.00% | – |
| Q3 2019 | $53,000 | -49.0% | 10,620 | -32.6% | 0.00% | – |
| Q2 2019 | $104,000 | +6.1% | 15,751 | +13.6% | 0.00% | – |
| Q1 2018 | $98,000 | -37.6% | 13,868 | -42.6% | 0.00% | – |
| Q4 2017 | $157,000 | +57.0% | 24,148 | -5.4% | 0.00% | – |
| Q1 2016 | $100,000 | +23.5% | 25,527 | +75.4% | 0.00% | – |
| Q4 2015 | $81,000 | – | 14,556 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 675,000 | $918,000 | 1.02% |
| Sargent Investment Group, LLC | 1,108,233 | $2,028,000 | 0.63% |
| Skylands Capital, LLC | 2,347,034 | $3,192,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 253,000 | $344,000 | 0.37% |
| Avenir Corp | 2,314,854 | $3,148,000 | 0.33% |
| Granahan Investment Management | 1,511,029 | $2,055,000 | 0.07% |
| ACT CAPITAL MANAGEMENT, LLC | 35,000 | $48,000 | 0.07% |
| Winning Points Advisors, LLC | 22,900 | $33,000 | 0.04% |
| Cowen Prime Advisors LLC | 42,200 | $57,000 | 0.03% |
| Seelaus Asset Management LLC | 23,900 | $33,000 | 0.03% |